Search results

Jump to navigation Jump to search
Results 21 – 40 of 109
Advanced search

Search in namespaces:

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  • substance of the arylcyclohexylamine class. It is a structural analog of MXE. The mechanism of action is not known, but it is likely an NMDA receptor antagonist
    17 KB (2,265 words) - 18:27, 14 January 2024
  • Wallach, J. (July 2014). "From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs: PCP to MXE". Drug Testing and Analysis. 6 (7–8):
    13 KB (1,828 words) - 21:19, 21 July 2022
  • when administered. It is structurally related to arylcyclohexylamines like MXE, 3-MeO-PCE, and deschloroketamine and is speculated to produce its effects
    16 KB (2,133 words) - 17:21, 17 March 2024
  • alongside diphenidine and methoxphenidine as a substitute for methoxetamine (MXE) despite users claiming markedly different effects. Very little data exists
    25 KB (3,096 words) - 09:43, 10 May 2024
  • resemble rather the effects of MXPr, MXE, DCK than more chaotic derivatives like O-PCE or MXiPr. Compared to MXE, it has less of a warmth to it and is
    12 KB (1,610 words) - 22:13, 5 December 2023
  • (PsychonautWiki) | https://psychonautwiki.org/wiki/3-MeO-PCP#Toxicity_and_harm_potential PCP Psychosis (PsychonautWiki) | https://psychonautwiki.org/wiki/3-M
    21 KB (2,634 words) - 00:21, 11 December 2023
  • similarities to other arylcyclohexylamine dissociatives such as 3-MeO-PCP, PCP and MXE. With this in mind, DCK is thought to act as an NMDA receptor antagonist.
    16 KB (2,011 words) - 23:32, 21 April 2024
  • severe injury, or death ☠. Memantine is more stimulating than ketamine or MXE but less so than PCP and its derivatives. Stimulation - Memantine is mildly
    17 KB (2,270 words) - 05:20, 1 May 2024
  • risk if not placed in the recovery position blackouts/memory loss likely. MXE - MXE can potentiate the effects of opioids but also increases the risk of respiratory
    22 KB (3,211 words) - 19:11, 7 April 2024
  • Jan 24, 2016. erowid.org/exp/103972 3-MeO-PCP (Tripsit) | https://wiki.tripsit.me/wiki/3-MeO-PCP
    5 KB (764 words) - 03:32, 5 February 2020
  • hypertension, tachycardia, seizures, and coma. Death has occurred in some cases. MXE - MXE can potentiate the effects of opioids but also increases the risk of respiratory
    19 KB (2,797 words) - 02:47, 12 May 2024
  • marketed by vendors as a replacement for the highly popular methoxetamine (MXE) despite little to no evidence that it possessed similar effects. Subjective
    21 KB (2,841 words) - 20:14, 22 July 2022
  • relatively "pure" dissociation, without as much stimulation and mania as PCP or MXE. Additionally, the effects of ketamine are highly dose-dependent. At lower
    57 KB (7,569 words) - 21:34, 6 May 2024
  • excessive blood pressure and heart strain (cardiotoxicity). MXE - Some reports suggest combinations with MXE may dangerously increase blood pressure and increase
    19 KB (2,841 words) - 14:21, 16 April 2024
  • excessive blood pressure and heart strain (cardiotoxicity). MXE - Some reports suggest combinations with MXE may dangerously increase blood pressure and increase
    13 KB (1,917 words) - 18:16, 30 April 2024
  • 2021 alongside other novel dissociatives designed to mimic the effects of MXE. The list also includes MXPr, MXiPr, DMXE, 3-F-PCP, 3-Me-PCP and HXE. 3-Cl-PCP
    15 KB (1,980 words) - 20:44, 21 July 2022
  • similarities to other arylcyclohexylamine dissociatives such as 3-MeO-PCP, PCP and MXE. With this in mind, 3-Meo-PCMo is thought to act as an NMDA receptor antagonist
    15 KB (2,255 words) - 21:04, 21 July 2022
  • excessive blood pressure and heart strain (cardiotoxicity). MXE - Some reports suggest combinations with MXE may dangerously increase blood pressure and increase
    12 KB (1,928 words) - 23:42, 21 April 2024
  • excessive blood pressure and heart strain (cardiotoxicity). MXE - Some reports suggest combinations with MXE may dangerously increase blood pressure and increase
    31 KB (4,254 words) - 15:15, 6 May 2024
  • Wallach, J. (July 2014). "From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs: PCP to MXE". Drug Testing and Analysis. 6 (7–8):
    20 KB (2,560 words) - 20:28, 17 January 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)